Zobrazeno 1 - 8
of 8
pro vyhledávání: '"David Gebben"'
Autor:
Olufemi Babalola, David Gebben, Michelle E. Tarver, Roopina Sangha, Jason Roberts, Veronica Price
Publikováno v:
Therapeutic Innovation & Regulatory Science.
Study Objective The purpose of this study is to rank the factors that are most and least important to patients with symptomatic uterine fibroids when considering surgical treatment options. Materials and Methods Using a best worst scaling (BWS) prefe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6f7877ad77dfe29cdf568b5ebac8756
https://doi.org/10.1007/s43441-023-00525-1
https://doi.org/10.1007/s43441-023-00525-1
Autor:
Shomesh E. Chaudhuri, Phillip Adamson, Dean Bruhn-Ding, Zied Ben Chaouch, David Gebben, Liliana Rincon-Gonzalez, Barry Liden, Shelby D. Reed, Anindita Saha, Daniel Schaber, Kenneth Stein, Michelle E. Tarver, Andrew W. Lo
Publikováno v:
The Patient - Patient-Centered Outcomes Research.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1885387ca61119a04f4e60e1c00cfbce
https://doi.org/10.1007/s40271-023-00623-0
https://doi.org/10.1007/s40271-023-00623-0
Publikováno v:
Patient Preference and Adherence. 14:2093-2104
Purpose Immuno-oncology treatments offer patients with advanced non-small cell lung cancer (NSCLC) treatment options with greater probability of durable survival and a different toxicity profile compared with traditional chemotherapy. The objective o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbea9628cb347a47d4c84bcec5548def
https://doi.org/10.2147/ppa.s248295
https://doi.org/10.2147/ppa.s248295
Publikováno v:
International Journal of MS Care. 19:172-183
Background: The growing number of treatments for relapsing multiple sclerosis (MS) provides opportunities to consider patient preferences in treatment decisions. Methods: We designed a Web-based, discrete-choice experiment survey to analyze treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4fcdb3cac7d7177ea84b7c98fd5ba7d7
https://doi.org/10.7224/1537-2073.2016-039
https://doi.org/10.7224/1537-2073.2016-039
Autor:
Neel Shah, Carol Mansfield, Jessie Sutphin, Sandhya Sapra, David Gebben, Stewart J. Tepper, Todd J. Schwedt
Publikováno v:
Headache. 59(5)
Objective To understand treatment preferences of people with migraine and the relative importance of improvements in efficacy and avoiding adverse events (AEs), such as cognition problems or weight gain. Background Current preventive migraine medicin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21f6d0ce84191eb8322972cff24b78e3
https://pubmed.ncbi.nlm.nih.gov/30861110
https://pubmed.ncbi.nlm.nih.gov/30861110
Publikováno v:
PharmacoEconomics. 36(8)
Value assessments of new treatments for metastatic renal cell carcinoma (RCC) should include outcomes that are most important to patients. This study aimed to quantify and compare the conditional relative importance of the attributes of RCC treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbb7a750270316d395009a301c79db48
https://pubmed.ncbi.nlm.nih.gov/29869777
https://pubmed.ncbi.nlm.nih.gov/29869777
Publikováno v:
Value in Health. 20:A450-A451
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::baae3f632e14018829d99798d10cb4c3
https://doi.org/10.1016/j.jval.2017.08.296
https://doi.org/10.1016/j.jval.2017.08.296
Publikováno v:
Value in Health. 18(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c954b850bb2345478cc3042c39297ac9